Robby Booth
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
Papers in
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 3
- Diabetes Management and Research 1
-
- COVID-19 Clinical Research Studies 1
- Co-authors
- Jordan Messler (3 shared papers)Raymie McFarland (3 shared papers)David Charles Klonoff (2 shared papers)Bruce W. Bode (2 shared papers)Guillermo E. Umpierrez (2 shared papers)Francisco J. Pasquel (2 shared papers)Joseph Aloi (2 shared papers)Limin Peng (1 shared paper)
- Journals
- Journal of Diabetes Science and Technology (2 papers)JAMA Network Open (1 paper)Diabetes Care (1 paper)
- Partner nations
- United States
In The Last Decade
Robby Booth
4 papers receiving 675 citations
Robby Booth's Hit Papers
Peers
Comparison fields: 5 of 49
- Infectious Diseases 415
- Endocrinology, Diabetes and Metabolism 324
- General Dentistry 1
- Modeling and Simulation 6
- Oncology 26
Countries citing papers authored by Robby Booth
This map shows the geographic impact of Robby Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robby Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robby Booth more than expected).
Fields of papers citing papers by Robby Booth
This network shows the impact of papers produced by Robby Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robby Booth. The network helps show where Robby Booth may publish in the future.
Co-authors
The 10 scholars most cited alongside Robby Booth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States Hit paper breakdown → | 2020 | 558 |
| 2 | 2020 | 68 | |
| 3 | 2021 | 52 | |
| 4 | 2016 | 32 |
About Robby Booth
Robby Booth is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases, Nuclear Energy and Engineering, Waste Management and Disposal and Organic Chemistry, having authored 4 papers that have together received 710 indexed citations. Recurring topics across this work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers), Diabetes Management and Research (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (415 citations), Endocrinology, Diabetes and Metabolism (324 citations), General Dentistry (1 citation), Modeling and Simulation (6 citations) and Oncology (26 citations). Robby Booth has collaborated with scholars based in United States. Frequent co-authors include Jordan Messler, Raymie McFarland, David Charles Klonoff, Bruce W. Bode, Guillermo E. Umpierrez, Francisco J. Pasquel, Joseph Aloi, Limin Peng, Jagdeesh Ullal and Amisha Wallia. Their work appears in journals such as Journal of Diabetes Science and Technology, JAMA Network Open and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.